pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
BioSpace·1h ago·1 min read
save

Biopharma layoffs in 2026 often marred by impersonal and poorly timed communications

Jul 30, 2026·read at BioSpace ↗LayoffsNegative

Over 50 biopharma companies have announced workforce cuts or plan to do so in 2026. According to a BioSpace survey, the manner in which these layoffs are communicated can leave a lasting negative impression on employees.

One respondent who was let go by a biotech described a Zoom call that felt scripted and impersonal, saying the experience made years of dedication feel unappreciated. Another former employee of Charles River Laboratories said the news arrived while they were at an airport, delivered through a Teams meeting with a department director and HR.

These anecdotes highlight that many firms are handling layoffs without thoughtful timing or personal touch, risking morale and reputation among their staff.

source

This writeup was produced by pharmadog from original reporting by BioSpace.

Original headline: “Not-so-special delivery: When biopharmas fumble layoff news”

read at BioSpace ↗
720 words · retrieved 1h ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 1h agoNew funding, new jobs: 4 biotechs hiring after series B raisesBioSpace
  • 4h agoBiogen validated the Alzheimer’s tau theory. CEO Viehbacher still isn’t betting the storeBioSpace
  • 9h agoFDA reviewers vote against approval of Capricor’s DMD therapy in chaotic adcomm meetingBioSpace
  • 13h agoPrivate biotechs Caldera and Vidya raise $478M collectively in reverse go-public mergersBioSpace
  • 17h agoBiogen shifts M&A strategy as Apellis acquisition pushes revenue above analyst expectationsBioSpace